Corebridge Financial’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-57,663
Closed -$7.34M 2184
2025
Q1
$7.34M Sell
57,663
-1,391
-2% -$214K 0.04% 507
2024
Q4
$8.5M Sell
59,054
-2,660
-4% -$381K 0.05% 464
2024
Q3
$9.18M Sell
61,714
-4,141
-6% -$594K 0.05% 446
2024
Q2
$8.3M Buy
+65,855
New +$10.3M 0.05% 486

Other funds holding RGEN

Corebridge Financial's RGEN Position: Q2 2025 in Review

Corebridge Financial sold out of Repligen (RGEN) in Q2 2025, closing a stake of 57,663 shares — an estimated $7.34M sold.

Corebridge Financial first reported a position in RGEN in Q2 2024 and held it in 4 quarters. The position peaked at $9.18M in Q3 2024. 444 funds tracked by Wall St. Rank hold RGEN as of Q2 2025.

  • Corebridge Financial reported no remaining Repligen position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 57,663 Repligen shares in Q2 2025, an estimated $7.34M.
  • Corebridge Financial first reported a position in Repligen in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's Repligen position peaked at $9.18M in Q3 2024.
  • 444 funds tracked by Wall St. Rank held Repligen as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.